Category: Regulatory
FDA Announces Generic Drug User Fee Rates for Fiscal Year 2027 (FY 2027)
FDA Announces Generic Drug User Fee Rates for Fiscal Year 2027 (FY 2027) The U.S. Food and Drug Administration (FDA) has released the FY 2027 Generic Drug User Fee Rates published under the Generic Drug User Fee Amendments of 2022 (GDUFA III). These fees are used to cover FDA review of generic drug applications, Drug… Continue reading FDA Announces Generic Drug User Fee Rates for Fiscal Year 2027 (FY 2027)
What Is SAHPRA? A Complete Guide to South Africa’s Health Products Regulatory Authority
What Is SAHPRA? A Complete Guide to South Africa’s Health Products Regulatory Authority The pharmaceutical industry depends on strong regulatory systems to ensure that medicines and medical products are safe, effective, and of high quality. In South Africa, this responsibility lies with the South African Health Products Regulatory Authority (SAHPRA).
Why Companies Choose End-to-End Regulatory Consulting Services for Faster Product Approvals
Why Companies Choose End-to-End Regulatory Consulting Services for Faster Product Approvals In today’s highly regulated pharmaceutical industry, faster product approvals are essential for staying competitive and delivering innovative medicines to patients on time.
What is DHF Documentation?
What is DHF Documentation? In the pharmaceutical and medical device industries, maintaining accurate documentation is essential for ensuring product quality, regulatory compliance, and patient safety.
Drug Product Labeling & SPL Submission: A Complete FDA Compliance Guide
Why Accurate Drug Product Labeling Matters The role of safe and effective use of drug products in drug product labelling is significant. It offers healthcare professionals and patients the information that is vital to know, such as indications, dosage, warnings, contraindications, how to store the medication, and how to use it.
FDA Regulatory Submission Mistakes: A Complete Guide for Pharmaceutical Companies
FDA Regulatory Submission Mistakes: A Complete Guide for Pharmaceutical Companies FDA regulatory submission are a critical milestone in the pharmaceutical product lifecycle, directly influencing approval timelines and market access. Whether submitting an IND, NDA, ANDA or BLA, pharmaceutical companies must ensure complete, accurate, and compliant documentation.
How eCTD Publishing Services Improve Submission Quality and Regulatory Efficiency
How eCTD Publishing Services Improve Submission Quality and Regulatory Efficiency In the pharmaceutical industry, regulatory submissions must meet strict global standards for accuracy and compliance. eCTD Publishing Services help pharmaceutical companies prepare, validate, and publish submission-ready dossiers in the Electronic Common Technical Document (eCTD) format.
Understanding FDA IND, NDA, ANDA & 505(b)(2) Submission Services for Pharmaceutical Companies
Understanding FDA IND, NDA, ANDA & 505(b)(2) Submission Services for Pharmaceutical Companies Bringing a pharmaceutical product to the U.S. market requires more than scientific innovation—it demands strict FDA regulatory compliance.
What Is PDF Conversion for eCTD Submissions?
What Is PDF Conversion for eCTD Submissions? In pharmaceutical regulatory submissions, document quality is just as important as the scientific data being submitted. Regulatory authorities require documents to be presented in a standardized electronic format that supports efficient review and compliance.
What Is FDA eCTD Submission Process?
What Is FDA eCTD Submission Process? The pharmaceutical industry relies on efficient regulatory submissions to bring safe and effective products to market. To standardize and streamline the review process, the U.S. Food and Drug Administration (FDA) requires most electronic regulatory submissions to be submitted in the Electronic Common Technical Document (eCTD) format.
